About Semler Scientific
Semler Scientific (NASDAQ:SMLR) specializes in developing, marketing, and deploying innovative technology solutions aimed at improving the clinical effectiveness and efficiency of healthcare providers. Primarily, its portfolio serves to support early detection and monitoring of chronic diseases, focusing emphatically on vascular and pulmonary conditions. Through its cutting-edge products, Semler Scientific endeavors to enhance patient outcomes while reducing overall healthcare costs. The company's flagship offering includes QuantaFlo, a system designed for the assessment of blood flow and diagnosis of peripheral arterial disease (PAD), showcasing its commitment to tackling significant medical challenges through technology. As of my last update, Semler Scientific is exclusively traded on the NASDAQ stock exchange under the ticker code SMLR, signifying its focus on innovation and growth within the medical technology sector.
Snapshot
Operations
Products and/or services of Semler Scientific
- QuantaFlo system for the early detection of peripheral arterial disease.
- Multi-test service for cardiovascular diseases and diabetes.
- WellChec platform for comprehensive testing services.
- Software solutions for vascular condition management.
- Remote patient monitoring and support services.
- Data analytics services for population health management.
Semler Scientific executive team
- Mr. Eric H. SemlerExecutive Chairman of the Board
- Dr. Douglas Murphy-Chutorian M.D.CEO, Interim CFO, President & Director
- Dr. Herbert J. Semler F.A.C.C., F.A.C.P, F.A.H., F.S.C.A.I., J.S., M.D.Founder & Chairman Emeritus
- Ms. Cindy GuinassoSenior Vice President of Business Development